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Available online 21 April 2012Psychotria is a complex genus whose neotropical species are known by the presence of glucosidic
monoterpene indole alkaloids. These compounds are able to display a large range of effects on the
central nervous system, such as anxiolytic, antidepressant, analgesic, and impairment of learning
and memory acquisition. The aims of this study were to investigate the effects displayed by
strictosidinic acid, isolated from Psychotria myrianthaMull. Arg. (Rubiaceae) leaves, onmonoamine
levels in rat hippocampus and on monoamine oxidase activity. A significance (pb0.01) of 83.5%
reduction in 5-HT levelswas observed after intra-hippocampal injection (20 μg/μl). After treatment
by intraperitoneal route (10 mg/kg), a 63.4% reduction in 5-HT levels and a 67.4% reduction in
DOPAC values were observed. The results indicate that strictosidinic acid seems to act on 5-HT
system in rat hippocampus, possibly inhibiting precursor enzymes of 5-HT biosynthesis. The
decrease verified in DOPAC levels suggests a role of strictosidinic acid in the dopaminergic
transmission, probably due to an inhibition of monoamine oxidase activity, confirmed by the
enzymatic assay, which demonstrated an inhibitory effect on MAO A in rat brain mitochondria.
© 2012 Elsevier B.V. Open access under the Elsevier OA license.Keywords:
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Psychotria (Rubiaceae) is a taxonomically complex genus
[1]. In the folk medicine Psychotria species are employed all
over the world in the treatment of several diseases such as:
diarrhea and intestinal parasites [2], snake bites [3], viral and
bacterial infections [4,5], hypertension, cardiovascular dys-
functions, mental disturbs and alimentary disorders [6].iversidade Federal do
00, Porto Alegre, RS
.
nriques).
lsevier OA license.,Psychotria viridis is one of themost cited species, probably due
to its effects on central nervous system. This specie, along with
P. carthagenensis and Banisteriopsis caapi, is constituent of the
hallucinogenic “ayahuasca” beverage, traditionally used for
religious practice in Amazonian region [7].
Neotropical species, belonging to the subgenusHeteropsycho-
tria, have been subjected to chemical and pharmacological
investigations, revealing the presence of bioactive glucosidic
monotepene indole alkaloids (MIAs) [8–14]. Psychollatine, the
major MIA isolated from Psychotria umbellata Vell., exhibited
mild analgesic effects against a number of algogenic stimuli [15],
anxiolytic (7.5 and 15 mg/kg) and antidepressant effects (3 and
7.5 mg/kg) inmicemodels [16,17]. In higher doses (100 mg/kg),
psychollatine impaired the acquisition of learning and memory
Fig. 1. Chemical structure of the alkaloid strictosidinic acid.
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neurotransmitter systems, such as glutamate, opioid and
serotonergic pathways. Alkaloid extract from Psychotria myr-
iantha Mull. Arg., a shrub occurring in southern Brazil, showed
dose-dependent analgesic effect (200 mg/kg), partially reversed
by naloxone in the hot plate model [18], suggesting the
involvement of NMDA receptors in its mechanism of action.
Strictosidinic acid, a glycoside indole monoterpene alkaloid
isolated from leaves of this specie, is able to inhibit in vitro
polymorphonuclear leukocytes (PMN) chemotaxis [13] and it
has shown peripheral analgesic and antipyretic activities inmice
after oral administration [19]. Moreover, strictosidinic acid
(10 mg/kg) seems to act on 5-HT andDA systems in rat striatum,
increasing the monoamines metabolism in this brain area [20].
Fractions of P. suterella and P. laciniata were able to inhibit
rat brain monoamine oxidase A (MAO-A) in concentrations
ranging from 0.5 to 135 μg/mL. The chemical analysis of the
active fractions suggested that the enzymatic inhibition
could be attributed to the alkaloids E/Z-vallesiachotamine
[21], which were previously described in other Psychotria
species.
Dopamine (DA), serotonin (5-HT) and their main metabo-
lites (3,4-hydroxyindoleacetic acid, DOPAC; homovanilic acid,
HVA; and 5-hydroxyindole acetic acid, 5-HIAA) represent
important monoamines and metabolites-derived neurotrans-
mitters. DA is one of the most important excitatory neuro-
transmitters, beingwidely distributed in themammalian brain,
including the hippocampus. The central dopaminergic trans-
mission is involved in a variety of behaviors andbrain functions,
includingmotor activity, cognition, emotion, positive reinforce-
ment, food intake and endocrine regulation [22]. The seroto-
nergic transmission on the CNS has been related with multiple
behaviors such as food intake, endocrine regulation, activity
rhythm, sexual behavior, sleep, and emotional states [23].
Alterations in 5-HT transmission are related with some
neurological and psychiatric illness including migraine, hallu-
cinations, anxiety and depression [24]. In addition, changes on
DA transmission are associated with Parkinson disease and
schizophrenia [25].
Monoamine oxidases (MAOs) are mitochondrial outer
membrane-bound flavoenzymes which catalyze the oxida-
tive deamination of several important neurotransmitters,
including 5-hydroxytryptamine (5-HT, or serotonin), hista-
mine and the catecholamines dopamine, norepinephrine and
epinephrine [26]. Two subtypes of MAO, MAO-A and MAO-B,
are similar in their primary sequences but have different
substrate and inhibitor affinities. MAO-A is inhibited by low
concentrations of clorgyline and catalyzes the oxidation of
5-HT, whereas MAO-B is inhibited by low concentrations of
l-deprenyl or pargyline and is active towards benzylamine
and 2-phenylethylamine. Dopamine, norepinephrine, trypt-
amine and tyramine are oxidized by both forms of the enzyme
in most species [26,27]. MAO-A inhibitors have been proven to
be effective in the pharmacological treatment of depression
and further developments have provided reversible inhibitors
of MAO-A, which offer antidepressant activity without the
serious side effects of the earlier inhibitors. On the other hand,
selective inhibitors of MAO-B have found a therapeutic role in
the treatment of Parkinson's disease [28].
Considering the relevance of monoamines (DA and 5-HT)
in brain functions and the previous results found to P.myriantha and strictosidinic acid, the aims of this study were
(i) to investigate the effect of intra-hippocampal and acute
intraperitoneal (i.p.) strictosidinic acid treatment in the mono-
amine levels and their metabolites in rat hippocampus, and (ii)
to evaluate the effect displayed by strictosidinic acid on MAO-A
and MAO-B activities, employing rat brain mitochondria as
enzymatic source.
Experimental methods
Chemicals
Dopamine (DA), 3,4-dihydroxyphenyl acetic acid (DOPAC),
3-metoxytyramine (3-MT), homovanillic acid (HVA), seroto-
nin (5-HT), 5-hydroxyindole-3-acetic acid (5-HIAA), kynur-
amine dihydrobromide, pargyline hydrochloride, clorgyline
hydrochloride, 4-hydroxyquinoline (4-OH), dimethyl sulfoxide
(DMSO), bovine albumin (BSA), HEPES and D-mannitol were
purchased from Sigma Chemical Co. (St. Louis, MO, USA). 3,4-
Dihydroxybenzylamine (DHBA) was obtained from Aldrich
Chemical Company Inc. (USA). Sucrose, potassium chloride and
sodium chloride were acquired from Labsynth (Diadema, SP,
Brazil). Sodiumphosphatemonobasicmonohydrate and sodium
phosphate dibasic dodecahydrate were purchased from Merck
(Darmstadt, Germany). All remaining chemicals used were of
analytical grade and were purchased from F. Maia (Cotia, SP,
Brazil). Stock solutions of kynuramine, pargyline, clorgyline
and 4-OHwere prepared in PBS buffer (pH7.4) andmaintained
at−20 °C for until six months.
Plant material
P. myriantha was collected in Reserva Estadual do Turvo,
Derrubadas, Rio Grande do Sul, Brazil and identified by
M. Sobral. A voucher specimen (M. Sobral et al., 8913) was
deposited in the ICN Herbarium (Universidade Federal do Rio
Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil).
Extraction and isolation
The alkaloid was extracted from leaves of P. myriantha as
previously described by Simões-Pires et al. [13]. Briefly, dried
leaves were extracted with EtOH at room temperature. The
extract was concentrated under vacuum at 40 °C and the
alkaloids fraction was obtained by acid/base extraction, being
the alkaline extracts partitioned with dichloromethane and n-
butanol. The butanolic extract was purified by semi-preparative
HPLC using Symmetry-Prep column (7 μm, 19×150 mm,
1140 F.M Farias et al. / Fitoterapia 83 (2012) 1138–1143Waters), MeOH:H2O (30:70) with Et3N 2 mM, flow rate 10 mL/
min, UV 254 nm) providing strictosidinic acid (Fig. 1), whose
structure was further elucidated by 1 and 2D NMR and HRMS
[7]. Before the biological experiments, strictosidinic acid was
submitted to UHPLC/HR-TOF-MS analyses in order to confirm its
identity and purity. The HRMS spectra of strictosidinic acid
afforded a pseudo-molecular ion at [M+H]+m/z 317.2181,
calculated for C26H33N2O9 (Supplementary Data).
Animals
Experiments for determination of monoamine levels in
hippocampuswere performedwithmaleWistar rats, weighing
200–250 g, acquired from Fundação Estadual de Produção e
Pesquisa em Saúde (FEPPS). The brain mitochondrial fractions
used in the enzymatic assays were obtained from male Wistar
rats (120 days old, 300–400 g) purchased fromBiotério Central
of Universidade Federal do RioGrande do Sul (UFRGS). Animals
were housed for one week in our animal facility, under
controlled environmental conditions (22±1 °C, 12 h light/
dark cycle, free access to food [commercial standard rodent
cube diet Nuvilab, CR1] and water), until the beginning of
experiments. All animal experiments were carried out in
accordance with the guidelines for care and use of experimen-
tal animals contained in the National Research Council Guide
for the Care and Use of Laboratory Animals. The experiments
were performed after approval by the University Ethics
Committee (# 2003139).
Brain monoamines
Treatments
For intra-hippocampal treatment, the animals were divided
in control (n=5) and treated (n=8) groups. The administra-
tion was realized by the infusion of a 20 μg/μl solution of
strictosidinic acid through canules implanted bilaterally 1 mm
above the pyramidal cells of the CA1 hippocampus sub-region.
The rats were euthanized by decapitation 15 min after the
injection and the hippocampus were removed, weighed and
stored at−80 °C until analysis for monoamine levels content.
The intraperitoneal (i.p.) treatmentwas performed in control
(n=4) and treated (n=5) groups; the last one received
strictosidinic acid 10 mg/kg. Sixty minutes after treatment
administration, rats were euthanized by decapitation, brains
were rapidly removed and hippocampus were dissected from
the surrounding tissue, weighed, frozen in liquid nitrogen and
stored at−80 °C until analysis for monoamine levels content.
HPLC-ED analysis
Hippocampus were homogenated in perchloric acid 0.1 M
with sodium bisulphite 1 mM (1:10 m/V) containing internal
standard 3,4-dihydroxybenzylamine (DHBA) in a concentration
of 1.6 μM, using a homogenizer (Ultra-Turrax T8, IKA Labor-
technik, Germany). The samples were then centrifuged at
14000×g, for 40 min at 4 °C and the supernatants, after
filtration, were injected onto high performance liquid chroma-
tography coupled with an electrochemical detection system
(HPLC-ED).
Monoamine determination in the hippocampal superna-
tants were carried out using an HPLC-ED technique previ-
ously reported [29] with some modifications and previouslyvalidated. The chromatographic system consisted of a Waters
510 pump (Waters, Milford, MA, USA) equipped with a 464
Pulse Electrochemical Detector (Waters, Milford, MA, USA)
and a Rheodyne injector (loop 20 μl). The glassy carbon
electrode potential was 800 mV (vs Ag/AgCl reference
electrode). Empower software was used for data acquisition
and peak integration. A Waters Spherisorb ODS1 column
(5 μm, 4.6×250 mm) was employed to separate the peaks.
The mobile phase consisted of 0.36 mM heptanesulfonic acid,
100 mM formic acid, 1 mM citric acid, 0.1 mM EDTA,
diethylamine (0.25% V/V), acetonitrile (2.2% V/V) adjusted
to pH 4.2–4.5 and filtered by vacuum thorough a 0.45 μm
filter, and degassed by vacuum prior to ultrasound bath to
eliminate air bubbles, which interferewith the electrochemical
assay. Analyseswere performed in isocratic mode at a flow rate
of 0.8 ml/min and at room temperature for a 35 min run time.
Student's t-test was employed for comparisons between
control and experimental groups and the resultswere expressed
as mean±S.E.M (standard error of the mean) from three
determinations. When the P value was b0.01 (*), the difference
was considered significant.
Monoamine oxidase inhibition assay
Preparation of brain mitochondria
Animals were euthanized by decapitation. Brains were
immediately removed and washed in ice-cold isolation
medium with the following composition: 10 mM HEPES;
68 mM sucrose; 10 mM KCl; 220 mM D-mannitol; and 0.1%
BSA (pH 7.4). Brain tissues were mechanically homogenized
in a Potter-Elvehjem tissue grinder in 10 vol. of the ice-cold
buffer. Then, tissue homogenates were centrifuged at 3000×g
for 10 min at 4 °C, and the supernatant was centrifuged at
11500×g for 15 min at 4 °C. After, the supernatantwas removed
and the resulting pellet was suspended in 3 ml of phosphate
buffered saline solution (PBS, pH 7.4) and stored at −80 °C.
Protein concentrations were determined by Peterson's modifi-
cation of the procedure proposed by Lowry and co-workers.
Enzymatic incubations
MAO inhibition assays were conducted with a fluorescence
method based in endpoint reading, using kynuramine as non-
selective substrate for MAO A and MAO B. The incubations
were performed according to previously reported by Van
Diermen et al. [30], with minor modifications. Briefly, assays
were carried out in black polystyrene 96-well microtiter plates
in a final volume of 200 μl. The concentration of kynuramine
was maintained in 50 μM, and the final protein concentration
was adjusted to 0.1 mg/ml.
For the MAO A inhibition assays, the wells containing
120 μl of PBS (pH 7.4), 5 μl of pargyline 10 μM (to get a final
concentration of 250 nM), 25 μl of the sample solution
prepared in PBS and DMSO (to get a final concentration of
1% DMSO), and 40 μl of the mitochondrial suspension (to get
a final protein concentration of 0.1 mg/ml) were preincu-
bated at 37 °C for 30 min. The MAO B inhibition assays were
performed in the same way that the MAO A incubations,
except by the use of 5 μl of clorgyline 10 μM to replace the
pargyline solution. As positive control for MAO activity
(without inhibition), 5 μl of a 40% DMSO solution (in PBS)
were used in place of the inhibitor, in the absence of samples.
Table 2
Monoamine levels in hippocampus after intra-hippocampal injection of
strictosidinic acid 20 μg/μl.
Monoamine Coefﬁcients of variation (%)
Intra-day Inter-day
DA 1.52 3.09
DOPAC 1.34 2.26
3-MT 0.79 0.88
HVA – –
1141F.M Farias et al. / Fitoterapia 83 (2012) 1138–1143As positive control for MAO A and MAO B activities, 5 μl of a
40% DMSO solution (in PBS) and 5 μl of pargyline 10 μM (or
clorgyline 10 μM) were used in the absence of the samples.
Strictosidinic acid was tested in concentrations ranging from
0.1 to 500 μg/ml (10 concentrations). Data analysis was
performed with Prism 5.0 (GraphPad Software, Inc., CA, USA).
The degree of inhibition IC50 was assessed by a sigmoidal
dose–response curve. The standard deviation was calculated
for sigmoidal regression.5-HT 3.79 3.33
5-HIAA 3.23 3.5
Table 3
Monoamine levels in hippocampus after intra-hippocampal injection of
strictosidinic acid 20 μg/μl.
Control (n=5) Treated (n=8)Results and discussion
In the present study, the concentrations of DA (and their
metabolites DOPAC and 3-MT) and 5-HT (and its metabolite
5-HIAA) were quantified by HPLC-ED in rat hippocampus after
two treatment schemes with strictosidinic acid: (1) 20 μg/μl by
intra-hippocampal injection, and (2) 10 mg/kg by acute intra
peritoneal administration. Complementary, the effect of stric-
tosidinic acid on MAO A and MAO B activities was evaluated in
mitochondrial fractions obtained from rat brain.
The HPLC-ED method was optimized and validated for the
parameters of linearity, limits of detection and quantification
(Table 1) and precision (Table 2), appearing to be appropriated
for monoamine determination in hippocampus homogenates.
When control and experimental group were compared, the
hippocampal levels of 5-HT were significantly (pb0.01) differ-
ent in intra-hippocampal treatment (Table 3), while the DOPAC
e 5-HT were significantly (pb0.01) altered in i.p. treatment
(Table 4).
There was an 83.5% reduction in the 5-HT levels after
intra-hippocampal injection. When rats received strictosidi-
nic acid by i.p. route, a 63.4% reduction in 5-HT levels, and
also a 67.4% reduction in DOPAC values were observed. In
spite of the fact that it is not possible to quantify DOPAC
levels in intra-hippocampal treatment, these results indicate
that the administration of strictosidinic acid by both routs share
the same profile. It is possible to believe that themetabolism of
strictosidinic acid can contribute to the differences found in
both routes of administration. The decrease verified in the
DOPAC levels after i.p. injection with strictosidinic acid couldTable 1
Summarization of results of the calibration curves for monoamine quantification.
Monoamine Equation of
calibration curve
r2
Valuea
Linearityb LODc LOQd
(ng) (ng/mL) (ng/mL)
DA y=9394.2 x
−5820960
0.9998 30–54 11.97 36.26
DOPAC y=6175.6 x
+95084
0.9995 1–5 10.22 30.96
3-MT y=6785.9 x
−461299
0.999 10–20 17.57 52.28
HVA y=6577 x
+116318
0.9999 1–5 1.6 4.86
5-HT y=6878.8 x
+252832
0.9999 1–10 0.23 0.7
5-HIAA y=3472 x
+40463
0.9996 1–5 7.62 23.1
a y=Peak area ratio; x=monoamine concentration.
b Correlation coefficient of calibration curve.
c Limit of detection.
d Limit of quantification.also suggest the effect of this alkaloid on monoamine oxidase
(MAO) activity in hippocampus. MAO A and MAO B are
mitochondrial enzymes that catalyze the oxidative deamina-
tion of monoamines to the correspondent aldehyde and free
amine, with generation of hydrogen peroxide. The aldehyde is
rapidly metabolized by aldehyde dehydrogenase to acidic
metabolites. DOPAC is the acidic metabolite from dopamine
and it is commonly used as themeasure ofMAO activity in vitro
and in vivo [21].
The effect of strictosidinic acid on MAO A and MAO B was
evaluated in mitochondrial fractions from rat brain. In
these assays, strictosidinic acid was able to inhibit MAO A
(IC50=150 ±1.25 μg/ml, maximum inhibition of 68.67%) in a
concentration dependent way (Fig. 2). On the other hand, this
MIA did not show to inhibitMAOBon the tested concentrations.
The inhibition observed onMAO A activity is in agreement with
the reduction inDOPAC levels in hippocampus, since that DA is a
non-selective substrate for MAO-A and B, being converted to
DOPAC by both enzymes. The brain mitochondrial fraction was
chosen for the enzymatic experiments because it presents high
protein content, allowing testing a great number of samples in
multiple concentrations.(nmol/g tissue) (nmol/g tissue)
DA 20.40±0.95 20.04±0.84
3-MT 9.75±1.24 9.86±1.24
5-HT 1.35±0.11 0.22±0.05⁎
5-HIAA 3.27±0.24 3.11±0.29
Results expressed as mean±standard error of the mean.
⁎ pb0.01, Student's t test.
Table 4
Monoamine levels in hippocampus after acute intraperitoneal injection of
strictosidinic acid 10 mg/kg.
Control (n=4) Treated (n=5)
(nmol/g tissue) (nmol/g tissue)
DA 9.32±0.94 7.89±0.37
DOPAC 1.72±0.09 0.56±0.09⁎
3-MT 8.52±0.82 7.19±0.97
5-HT 1.44±0,12 0.52±0.04⁎
5-HIAA 0.56±0.10 0.70±0.07
Results expressed as mean±standard error of the mean.
⁎ pb0.01, Student's t test.
Fig. 2. Effects displayed by strictosidinic acid on MAO-A activity. Strictosi-
dinic acid was tested in ten different concentrations ranging from 0.1 to
500 μg/ml. The degree of inhibition IC50 was assessed by a sigmoidal dose–
response curve. Each point represents the mean±SMD of the sigmoidal
regression for two independent determinations. (IC50=150.1±1.25 μg/ml;
maximum inhibition=68.67; Hill Coefficient 1.341; R2=0.9816).
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ninmetabolism indicator, since it establishes the 5-HT consume
and the formation of its metabolization product [31]. The
results obtained in the hippocampus analyses of rats treated
with 20 μg/μl strictosidinic acid by intra-hippocampal injection
and 10 mg/kg strictosidinic acid i.p. resulted in the reduction of
5-HT tissue levels, without the consequent increase of 5-HIAA
values, indicating no increase of 5-HT metabolism in this
structure. This may be due to the block of 5-HT synthesis,
which is in accordance with previous findings where the
inhibition of 5-HT synthesis by p-chloroamphetamine reduced
the levels of this indolamine in brain structures evaluated [32].
Tryptophan is the biosynthetic precursor of 5-HT through
the tryptophan hydroxilase action. The disponibility of this
essential amino acid and the activity of this enzyme are the
mainly regulatory processes of 5-HT formation. In this way,
the tryptophan lack can lead to a 5-HT deficiency in the brain
[31]. The monoterpene indole alkaloids are biosynthesized
through tryptophan decarboxylation, showing the existence
of a common precursor between 5-HT and strictosidinic acid.
Therefore, it is possible to imagine an action of strictosidinic
acid in the precursor enzymes of 5-HT, which can justify the
reduction observed in the hippocampus. The role of 5-HT in
learning and memory is not clearly known, but there are
many reports indicating the relationship between the use of
5-HT antagonists and the facilitation of learning and memory
processes [33].
Broadly, themonoterpene indole alkaloid strictosidinic acid
seems to act on 5-HT system in rat hippocampus, reducing the
5-HT levels. Regarding the importance of monoamines to
central nervous system performance and their involvement in
neurodegenerative diseases, the results presented in this work
indicate that strictosidinic acid plays a role in 5-HT system
towards a decrease of its levels. This suggests that the further
investigation of P. myriantha and strictosidinic acid, using
pharmacological models of depression, learning and memory
tasks, is worthwhile.
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